Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial

Publisher: John Wiley & Sons Inc

E-ISSN: 2047-9980|4|12|JAHA.115.002340-JAHA.115.002340

ISSN: 2047-9980

Source: JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.4, Iss.12, 2015-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content